Related Experiment Video
Updated: Apr 14, 2026
06:18
A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
2.0K
Optimal vancomycin doses for methicillin-resistant Staphylococcus aureus infection in urological renal dysfunction
Katsumi Shigemura1, Kayo Osawa, Fukashi Yamamichi
1Division of Urology, Department of Organ Therapeutics, Faculty of Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan, yutoshunta@hotmail.co.jp.
International Urology and Nephrology
|April 23, 2015
Summary
The optimal vancomycin (VCM) dose for methicillin-resistant Staphylococcus aureus infections in urological patients depends on kidney function. Adjusting VCM dosage based on estimated glomerular filtration rate (eGFR) is crucial for effective treatment in patients with varying renal impairment.
Area of Science:
- Pharmacology
- Nephrology
- Infectious Diseases
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen in urological infections.
- Vancomycin (VCM) is a primary treatment for MRSA, but its efficacy depends on achieving therapeutic trough concentrations.
- Renal dysfunction can alter VCM pharmacokinetics, necessitating dose adjustments.
Purpose of the Study:
- To determine the optimal vancomycin (VCM) dosage for treating methicillin-resistant Staphylococcus aureus (MRSA) infections in urological patients.
- To investigate the relationship between VCM dosage, VCM trough levels, and estimated glomerular filtration rate (eGFR) in this patient population.
- To assess the impact of varying renal function on VCM dosing strategies.
Main Methods:
- Analysis of 143 patient datasets from a urological department.
- Correlation of VCM dose, VCM trough levels, and eGFR at the time of trough examination.
- Regression analysis to model the relationship between VCM dose and VCM trough levels across different eGFR categories.
Main Results:
- The median VCM dose was 1000 mg/day, with a mean VCM trough of 15.6 μg/ml and a mean eGFR of 61.1 ml/min/1.73 m².
- Statistically significant regression models for VCM dose and trough levels were found in patients with eGFR between 30-60 ml/min/1.73 m² and 60-90 ml/min/1.73 m².
- These relationships remained significant with or without body weight adjustments for VCM doses.
Conclusions:
- The optimal vancomycin (VCM) dose for MRSA infections in urological patients is variable and significantly influenced by the patient's estimated glomerular filtration rate (eGFR).
- Individualized VCM dosing strategies tailored to renal function are essential for optimizing treatment outcomes in urological patients with MRSA.
- These findings underscore the importance of monitoring renal function to guide VCM therapy in this specific patient group.
Related Concept Videos
01:20Estimation of k and VD of Aminoglycosides
310
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
310
01:11Renal Failure: Dose Adjustments
624
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
624
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
332
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
332
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
356
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
356
01:25Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
359
In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
359
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
318
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
318